We used a salivary multiplex immunoassay targeting IgG responses to SARS-CoV-2 nucleocapsid (N), receptor-binding domain (RBD), and spike (S) protein to differentiate between infection-induced versus infection- and/or vaccination-induced immune response. The gene discussed is CHMP5; the disease is infection.